ArticleJournal of ovarian research2026
Genetically predicted inflammatory cytokines mediate the associations between the gut microbiota and ovarian cancer: a bidirectional two-sample Mendelian randomization study.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOvarian cancer (OC), the deadliest gynecologic malignancy, lacks effective strategies for early detection and treatment. Emerging evidence suggests that the gut microbiota and inflammatory cytokines may influence OC pathogenesis, but the causal mechanisms remain unclear. This study employed a bidirectional, two-sample Mendelian randomization (MR) analysis with genetic mediation analysis to investigate whether genetically predicted inflammatory cytokines mediate the associations between the gut microbiota and OC.
methodsThis study was based on an analysis of public genetic summary statistics from predominantly European populations. The data from a genome-wide association study (GWAS) and public databases included 473 gut microbiotas (FinnGen, n = 5,959), 91 inflammatory cytokines (GWAS, n = 14,824), and 1,218 OC cases (UK Biobank). Inverse-variance weighted (IVW) was the primary MR method, supplemented by multiple methods such as MR-Egger and other sensitivity analyses to evaluate the robustness of findings. Single-nucleotide polymorphisms (SNPs) associated with exposure were selected as instrumental variables (IVs). Mediation analysis was conducted to explore the potential mediation effect of inflammatory cytokines.
resultsOur analysis identified 19 gut microbiotas (9 risk, 10 protective) and 5 inflammatory cytokines (4 risk, 1 protective) with associations suggestive of causality with OC under MR assumptions (PFDR<0.05). Mediation analysis revealed that interleukin-6 (IL-6) mediated 14.67% and 16.63% of the effects of Bacillaceae A and Prevotella sp000434975 on OC risk, respectively. Similarly, T-cell surface glycoprotein CD6 and leukemia inhibitory factor receptor (LIFR) accounted for 6.06% and 11.16% of the mediating effects for Bacillaceae A and Gluconobacter, respectively. Reverse MR suggested potential bidirectional interactions, with OC being associated with alterations in 18 gut microbiotas and 3 inflammatory cytokines.
conclusionThis MR study provides genetic evidence suggestive of a potential mechanism whereby the gut microbiota might influence OC risk partly through inflammatory cytokines, notably IL-6, CD6, and LIFR. These findings suggest these cytokines as potential risk markers and implicate pathways involving both microbiota modulation and cytokine activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.